Machine learning to predict lymph node metastasis in T1 esophageal squamous cell carcinoma: a multicenter study
Xu Huang1, Qingle Wang2, Wenyi Xu1
1Department of Thoracic Surgery, Zhongshan Hospital, Fudan University Shanghai, China.
International Journal of Surgery (London, England)
|June 21, 2024
Summary
Machine learning models significantly improve the prediction of lymph node metastases (LNM) in T1 esophageal squamous cell carcinoma (ESCC). Elastic net regression achieved the best performance, outperforming current guidelines for LNM risk assessment.
Area of Science:
- Oncology
- Medical Informatics
- Machine Learning in Medicine
Background:
- Accurate quantification of lymph node metastases (LNM) risk is crucial for T1 esophageal squamous cell carcinoma (ESCC) staging and treatment.
- Existing models demonstrate limitations in precisely assessing LNM risk in early-stage ESCC.
Purpose of the Study:
- To develop and evaluate machine learning (ML) models for predicting LNM in patients with T1 ESCC.
- To compare the performance of ML models against established guidelines and traditional statistical methods.
Main Methods:
- A multicenter, population-based study was conducted.
- Several ML algorithms were developed, including Elastic Net Regression (ELR), Random Forest (RF), and Extreme Gradient Boosting (XGB), along with an ensemble model.
- Model performance was assessed using externally validated Area Under the Curve (AUC).
Main Results:
- All developed ML models demonstrated strong discriminating power for LNM prediction.
- Elastic Net Regression (ELR) achieved the highest externally validated AUC of 0.803.
- Key predictive features identified were lymphatic invasion, vascular invasion, and depth of tumor invasion.
- ELR performance significantly surpassed the NCCN guidelines (AUC=0.576) and a standard logistic model (AUC=0.670).
Conclusions:
- Machine learning approaches offer a highly effective strategy for estimating LNM risk in T1 ESCC.
- The developed ML models provide a superior tool for risk stratification compared to current clinical guidelines.


